Ssd Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
About Ssd Pharmaceuticals
Ssd Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 February 2020 (Four years and 11 months 12 days old ). Its registered office is in Godavari, Andhra Pradesh, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Siva Bairi and Chandrasekhar Bejjipuram serve as directors at the Company.
Company Details
- Location
Godavari, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24110AP2020PTC114207
- Company No.
114207
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Ssd Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siva Bairi  | Director | 31-Jul-2021 | Current |
| Chandrasekhar Bejjipuram | Director | 31-Jul-2021 | Current |
Financial Performance of Ssd Pharmaceuticals.
Enhance accessibility to Ssd Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ssd Pharmaceuticals?
Unlock access to Ssd Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kalpatharuvu Techno Feeds Private LimitedSiva Bairi and Chandrasekhar Bejjipuram are mutual person
- Ssd Interior Projects Private Limited
Siva Bairi and Chandrasekhar Bejjipuram are mutual person
- Ssd Energy Private Limited
Siva Bairi and Chandrasekhar Bejjipuram are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ssd Pharmaceuticals?
Unlock and access historical data on people associated with Ssd Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ssd Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ssd Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
